BioWorld MedTech

May 15, 2012

MedTech Investing Conference: Changing partnership models reflect new paths to business

MINNEAPOLIS Things go in cycles, they say. That certainly appears to be true insofar as pharmaceutical company ownership of medical device companies is concerned. Read More

HRS 2012: New AF mapping technology data may finally silence the skeptics

Maquet wins FDA clearance for new MEGA IAB catheters

Washington roundup: Authors hint 'multi-specialty' needed for knee replacements

Report from Europe: Boston Scientific receives CE mark for Innova BMS system

Coming Wednesday in MDD Perspectives

Agreements/contracts: Philips to sell Boston Sci cath imaging equipment

Financings roundup: Regentis raises $10M for knee cartilage regeneration product

Patent watch: Excelsior Medical gains patents for antiseptic cap technology

Court report: ICU Medical to seek damages in wake of victory over RyMed

Med-Tech Notes: Boston Sci offers warranties on defibrillators

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...